Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Human Immunodeficiency Virus-type 1 Infection”

1,964 trials

Showing 20 of 1,964 results

Testing effectiveness (Phase 2)Study completedNCT00001132
What this trial is testing

Effectiveness of the Early Addition of Abacavir to an Anti-HIV Drug Combination

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 80
Large-scale testing (Phase 3)Study completedNCT00144287
What this trial is testing

Safety Study of Tipranavir Co-administered With Low-dose Ritonavir (TPV/r) in Patients With Advanced HIV-1 Infection and Limited Treatment Options

Who this might be right for
HIV Infections
Boehringer Ingelheim 255
Post-approval studies (Phase 4)Looking for participantsNCT04553081
What this trial is testing

2DR Versus 3DR in a Prospective Randomized Controlled Switch Trial

Who this might be right for
HIV-1-infection
University Hospital, Ghent 134
Large-scale testing (Phase 3)Study completedNCT00323544
What this trial is testing

SWEET: Once Daily Truvada Versus Twice Daily Combivir for the Treatment of HIV Infection

Who this might be right for
HIV Infections
Gilead Sciences 220
Testing effectiveness (Phase 2)Study completedNCT02412436
What this trial is testing

PK Study of Rifampicin Interactions With DMPA and Efavirenz in TB

Who this might be right for
HIV-1 InfectionTuberculosis
Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections 62
Testing effectiveness (Phase 2)WithdrawnNCT05130086
What this trial is testing

Islatravir (MK-8591) in Trans and Gender Diverse Participants (MK-8591-035)

Who this might be right for
Human Immunodeficiency Virus (HIV) Infections
Merck Sharp & Dohme LLC
Early research (Phase 1)Study completedNCT03803605
What this trial is testing

Study to Assess Safety and Activity of Combination Therapy of VRC07-523LS and Vorinostat on HIV-infected Persons

Who this might be right for
HIV-1 Infection
University of North Carolina, Chapel Hill 15
Early research (Phase 1)Study completedNCT01103687
What this trial is testing

Evaluating the Safety and Immune Response of an Adenovirus-Based HIV Vaccine in HIV-Uninfected Adults

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 24
Early research (Phase 1)Study completedNCT02818348
What this trial is testing

Clinical Trial to Evaluate Drug-drug Interactions Between Darunavir/Cobicistat and Etravirine in Hiv- Infected Patients

Who this might be right for
HIV-1 Infection
Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia 30
Large-scale testing (Phase 3)Looking for participantsNCT07044297
What this trial is testing

A Clinical Study of MK-8527 to Prevent Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8527-011)

Who this might be right for
Human Immunodeficiency Virus (HIV)HIV Pre-Exposure Prophylaxis
Merck Sharp & Dohme LLC 4,390
Early research (Phase 1)Study completedNCT00000738
What this trial is testing

Randomized, Double-Blind, Placebo-Controlled Trial of Nimodipine for the Neurological Manifestations of HIV-1

Who this might be right for
AIDS Dementia ComplexHIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 36
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06626555
What this trial is testing

Clinical Trial to Evaluate the Effects of Letermovir Prophylaxis on T-cell Immune Activation in Participants With Treated HIV-1 Infection

Who this might be right for
HIV
University College, London 36
Large-scale testing (Phase 3)Study completedNCT01780506
What this trial is testing

Study to Evaluate the Safety and Efficacy of E/C/F/TAF (Genvoya®) Versus E/C/F/TDF (Stribild®) in HIV-1 Positive, Antiretroviral Treatment-Naive Adults

Who this might be right for
HIVHIV Infections
Gilead Sciences 872
Testing effectiveness (Phase 2)Study completedNCT01935089
What this trial is testing

Pilot Peg-Interferon-a2b in Decreasing Viral DNA in HIV

Who this might be right for
HIV-1 Infection
The Wistar Institute 20
Testing effectiveness (Phase 2)Study completedNCT00992017
What this trial is testing

Safety of and Immune Response to an H1N1 Influenza Vaccine in HIV Infected Pregnant Women

Who this might be right for
HIV InfectionsH1N1 Influenza Virus
National Institute of Allergy and Infectious Diseases (NIAID) 130
Post-approval studies (Phase 4)Study completedNCT00549198
What this trial is testing

KIVEXA Vs TRUVADA, Both Administered With Efavirenz, In ART-Naive Subjects

Who this might be right for
Infection, Human Immunodeficiency Virus IHIV Infection
GlaxoSmithKline 392
Large-scale testing (Phase 3)Study completedNCT03297216
What this trial is testing

Improving Pregnancy Outcomes With Progesterone

Who this might be right for
Pre-term BirthHIV-1-infection
University of North Carolina, Chapel Hill 800
Large-scale testing (Phase 3)Study completedNCT01263015
What this trial is testing

A Trial Comparing GSK1349572 50mg Plus Abacavir/Lamivudine Once Daily to Atripla (Also Called The SINGLE Trial)

Who this might be right for
Infection, Human Immunodeficiency Virus I
ViiV Healthcare 844
Testing effectiveness (Phase 2)Study completedNCT00002390
What this trial is testing

The Safety and Effectiveness of Different Doses of 1592U89 in HIV-Infected Patients

Who this might be right for
HIV Infections
Glaxo Wellcome
Early research (Phase 1)Study completedNCT00982878
What this trial is testing

The Maraviroc Central Nervous System (CNS) Study

Who this might be right for
HIV Infections
Imperial College London 13
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation